Rigosertib versus best supportive care for patients with high-risk myelodysplastic syndromes after failure of hypomethylating drugs (ONTIME): a randomised, controlled, phase 3 trial
|
Mar 2016
|
Lancet Oncol
|
myelodysplastic syndromes (MDS)
|
Risk and timing of cardiovascular death among patients with myelodysplastic syndromes
|
Oct 2017
|
Blood Advances
|
myelodysplastic syndromes (MDS)
|
Risk factors for de novo and therapy-related myelodysplastic syndromes (MDS)
|
Jan 2021
|
Cancer Causes & Control : CCC
|
myelodysplastic syndromes (MDS)
|
Risk for developing myelodysplastic syndromes in prostate cancer patients definitively treated with radiation
|
Mar 2014
|
J Natl Cancer Inst
|
myelodysplastic syndromes (MDS)
|
Risk of acute leukemia and myelodysplastic syndromes in patients with monoclonal gammopathy of undetermined significance (MGUS): a population-based study of 17 315 patients
|
Feb 2013
|
Leukemia
|
myelodysplastic syndromes (MDS)
|
Risk stratification in myelodysplastic syndromes: is there a role for gene expression profiling?
|
Feb 2014
|
Expert Rev Hematol
|
myelodysplastic syndromes (MDS)
|
Risk-Adapted, Individualized Treatment Strategies of Myelodysplastic Syndromes (MDS) and Chronic Myelomonocytic Leukemia (CMML)
|
Mar 2021
|
Cancers
|
chronic myelomonocytic leukaemia (CMML), myelodysplastic syndromes (MDS)
|
Role of Reduced-Intensity Conditioning Allogeneic Hematopoietic Stem-Cell Transplantation in Older Patients With De Novo Myelodysplastic Syndromes: An International Collaborative Decision Analysis.
|
Jun 2013
|
J Clin Oncol
|
myelodysplastic syndromes (MDS)
|
Romiplostim monotherapy in thrombocytopenic patients with myelodysplastic syndromes: long-term safety and efficacy
|
Jun 2017
|
Br J Haematol
|
myelodysplastic syndromes (MDS)
|
Safety and activity of selinexor in patients with myelodysplastic syndromes or oligoblastic acute myeloid leukaemia refractory to hypomethylating agents: a single-centre, single-arm, phase 2 trial
|
Aug 2020
|
Lancet Hematology
|
acute myeloid leukemia (AML), myelodysplastic syndromes (MDS)
|